Evidence map›Paper›PMID 40788584›Full record

ArticleDiscover oncology2025

Chemoradiotherapy for recurrent CBTs case report.

Guangyu Liu, Shuangyan Zhao, Jiankai Wang, Xiaoyu Duan, Hongyi Cai

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guangyu Liu *Gansu University of Chinese Medicine, No. 35, Dingxi East Road, 730000, Lanzhou, China.
Shuangyan Zhao *Gansu University of Chinese Medicine, No. 35, Dingxi East Road, 730000, Lanzhou, China.
Jiankai Wang *Department of Radiotherapy, Gansu Provincal Hospital, No. 204, Donggang West Road, Lanzhou, China.
Xiaoyu DuanDepartment of Radiotherapy, Gansu Provincal Hospital, No. 204, Donggang West Road, Lanzhou, China.
Hongyi CaiDepartment of Radiotherapy, Gansu Provincal Hospital, No. 204, Donggang West Road, Lanzhou, China. gschy333@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarotid body tumors (CBTs) are rare paragangliomas with an incidence of 1-2 per 100,000 individuals. While surgical resection remains the standard treatment, postoperative recurrence poses a clinical challenge. CASE PRESENTATION: We describe a 49-year-old female with recurrent CBT involving the jugular foramen, managed with IGRT (60 Gy/30 fractions) and 4 cycles of CVD chemotherapy. Post-treatment RECIST evaluation revealed stable disease, supporting chemoradiotherapy as a salvage option for anatomically complex recurrences.

conclusionThis case underscores the necessity for standardized protocols and further research to validate multimodal therapy in recurrent CBTs.

Indexed as

Carotid body tumorChemoradiotherapyCVD regimenRecurrence

Identifiers

PMID40788584
PMCPMC12339781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.